Welcome to LookChem.com Sign In|Join Free

CAS

  • or

192517-47-8

Post Buying Request

192517-47-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

192517-47-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 192517-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,2,5,1 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 192517-47:
(8*1)+(7*9)+(6*2)+(5*5)+(4*1)+(3*7)+(2*4)+(1*7)=148
148 % 10 = 8
So 192517-47-8 is a valid CAS Registry Number.

192517-47-8Relevant articles and documents

SuFExable Isocyanides for Ugi Reaction: Synthesis of Sulfonyl Fluoro Peptides

Xu, Shuheng,Cui, Sunliang

supporting information, p. 5197 - 5202 (2021/07/20)

Herein, the sulfonyl fluoro isocyanides were first developed as a new type of SuFExable synthon, and they are used as building blocks in the Ugi reaction (U-4CR). The Ugi reaction was established and the substrate scope was investigated, and various sulfonyl fluoro α-amino amides and peptides could be reached in a one-step synthesis. Therefore, this protocol opens a new vision for SuFExable building blocks and click chemistry, and it also provides a distinct approach to sulfonyl fluoro peptides.

Synthesis of (-)-dihydropinidine, (2S,6R)-isosolenopsin and (+)-monomorine via a chiral synthon from l-aspartic acid

Reddy, Chada Raji,Latha, Bellamkonda

experimental part, p. 1849 - 1854 (2012/02/05)

The use of a β-amino aldehyde derived from l-aspartic acid as a chiral synthon to construct 2,6-disubstituted piperidines is described. The synthesis of (-)-dihydropinidine·HCl, (2S,6R)-isosolenopsin·HCl and (+)-monomorine has been achieved from this chiral synthon using a Wittig reaction followed by hydrogenation (reductive cyclization) as the key steps.

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

-

Page/Page column 268-270, (2008/06/13)

Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 192517-47-8